Breaking Finance News

Zacks Investment Research upgraded Community Healthcare Trust Inc (NYSE:CHCT) to Hold in a report released today.

Yesterday Community Healthcare Trust Inc (NYSE:CHCT) traded -0.40% lower at $22.67. The company’s 50-day moving average is $22.28 and its 200-day moving average is $20.71. The last stock close price is up 9.02% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 43,768 shares of the stock were exchanged, down from an average trading volume of 80,349

Zacks Investment Research has upgraded Community Healthcare Trust Inc (NYSE:CHCT) to Hold in a report released on Monday October 10, 2016.

See Chart Below

Community Healthcare Trust Inc (NYSE:CHCT)

Community Healthcare Trust Inc has a 52 week low of $15.87 and a 52 week high of $23.70 with a P/E ratio of 305.14 The company’s market cap is currently $0.

About Community Healthcare Trust Inc (NYSE:CHCT)

Community Healthcare Trust Incorporated is an integrated healthcare real estate company. The Company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The Company holds interests in approximately 40 real estate properties and mortgage notes, located in over 20 states, totaling approximately 789,500 square feet. Its medical offices are located in Alabama, Florida, Georgia, Illinois, Kansas, Kentucky, Ohio and Texas. The Company's physician clinics are located in Alabama, Arizona, Florida, Kansas, Pennsylvania, Virginia and Wisconsin. Its ambulatory surgery centers are located in Arizona, Colorado, Michigan, Ohio, Pennsylvania, South Carolina and Texas. The Company's dialysis clinics are located in Colorado, Georgia, Kentucky, Ohio, Tennessee and Texas. The Company's oncology centers are located in Alabama. Its behavioral facilities are located in Indiana.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *